Status:
COMPLETED
Renoprotective Effect of Nisoldipine and Lisinopril in Type 1 Diabetic Nephropathy
Lead Sponsor:
Steno Diabetes Center Copenhagen
Collaborating Sponsors:
Bayer
Conditions:
Diabetic Nephropathy
Eligibility:
All Genders
18-55 years
Phase:
PHASE4
Brief Summary
The aim of the study was to compare the renoprotective effect of a long acting calcium antagonist (nisoldipine) with an angiotensin converting enzyme inhibitor (lisinopril)in type 1 diabetic patients ...
Eligibility Criteria
Inclusion
- diabetic nephropathy, type 1 diabetes, hypertension
Exclusion
- child bearing potential, non-diabetic kidney disease, malignancy
Key Trial Info
Start Date :
March 1 1993
Trial Type :
INTERVENTIONAL
End Date :
April 1 1999
Estimated Enrollment :
52 Patients enrolled
Trial Details
Trial ID
NCT00311870
Start Date
March 1 1993
End Date
April 1 1999
Last Update
April 6 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Steno Diabetes Center
Gentofte Municipality, Denmark, DK-2820